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SUMMARY 
 
        Introduction 
Obesity is fast becoming a global health pandemic. Characterized by an increase in 
adipose tissue to the point where it is associated with adverse health effects, the 
prevalence of obesity has nearly tripled over the past fifty years.  Obesity has an 
enormous economic burden and is the second leading cause of preventable death. The 
molecular and cellular processes that regulate fat mass remain almost entirely 
unknown.  White adipose tissue is the only tissue in the body that can markedly change 
its mass after adult size is reached.  Indeed, fat mass can range from 2-3% of body 
weight to as much as 60-70% of body weight in humans.  It is widely believed that the 
total number of fat cells present in most individuals is set during adolescence and that 
changes in fat mass generally reflect increased lipid storage in a fixed number of 
adipocytes. It was recently demonstrated that there is a substantial degree of cellular 
turnover within the human adipocyte population and the source of new adipocytes 
during one’s lifetime is attributed to the differentiation of new adipocytes from 
preadipocytes and/or stem cells.  
New adipocytes are thought to arise from a pool of progenitors that has recently been 
described and may reside adjacent to the adipose vascular tissue.  A population of cells 
can also be purified based on cell surface marker expression and transplanted into 
lipodystrophic mice to reconstitute fat depots.  Preadipocytes are generally considered 
to be replicative until the onset of a transcription factor cascade drives adipogenesis 
and causes growth arrest. Additionally, primary adipocytes seemingly lack proliferative 
activity in vitro and cell culture lines capable of adipocyte differentiation undergo cell 
cycle arrest during differentiation. Adipocytes are thought to represent a terminal stage 
of differentiation and are widely believed to lack proliferative ability. 
How adipose tissue is regulated is a central question in the study of obesity. Obesity is 
commonly considered to be a disorder of energy imbalance in the organism.  At the 
cellular level, however, the development of obesity has been attributed to both an 
increase in fat cell size, fat cell differentiation and increased adipocyte number. The 
notion that adipocytes can undergo replication has existed for decades  but has not been 
widely accepted. 
There are many important questions that are still open and unresolved: for example 
how do adipocytes form during development, how is proliferation regulated in adipose 
tissue, what are the dynamics of progenitors and how they are regulated during 
development and obesity….  
Thus, an understanding of how adipocytes number is regulated postnatally has the 
potential to expand our knowledge of the pathogenesis of obesity, and may open up 
possibilities for novel therapeutic approaches that may prove to be of great importance 
in the treatment of obesity and diseases associated with obesity. 
 
         Experimental approach 
We sought to investigate the growth and maintenance of adipose tissue and its behavior 
in the cell cycle through 4 independent experimental  approaches: 
1)  dilution of an inducible histone 2B-green fluorescent protein (H2BGFP)   through    
cell division. 
2) DNA-replication dependent incorporation of the nucleotide analog BrdU. 
3) labeling with the cell cycle marker Ki67 and PCNA 
4) lineage analysis of adipose tissue by using AP2-CreER transgenic mice to 
investigate whether newly formed fat cells are derived from pre-existing 
adipocytes or stem/precursor cell 
          Materials and methods 
         Mice 
Rosa26-rtTA, tetO-H2BGFP and AP2-CreER mice were generously provided by 
Rudolf Jaenisch, Elaine Fuchs and Daniel Metzger and Pierre Chambon, respectively. 
Rosa26-rtTA and tetO-H2BGFP mice were backcrossed to >95% C57BL/6 inbred 
background.  OB/OB, R26R and Rosa26-lacZ mice were obtained from JAX. 
 
 Genotyping 
Genotyping was performed by adding a tail biopsy to 100µl DirectPCR (Viagen) with 
30µg Proteinase K (Roche), incubating overnight at 55°C and denaturing Proteinase K 
for 20 minutes at 95°C.  PCR conditions: 95°C for 5 minutes, then 35 cycles of 95°C 
for 30 seconds, 55°C for 30 seconds, 72°C for 60 seconds, and finally 72°C for 5 
minutes.  
 
  Doxycycline, BrdU and Tamoxifen 
Doxycycline (Sigma) was added to drinking water at 1mg/ml and sweetened with 
sucrose (1%)..  Animals were injected with 100 µl of 10mg/ml BrdU (Sigma) or 300µl 
BrdU Labeling Reagent (RPN201, Amersham). Tamoxifen (Sigma, 
http://www.sigmaaldrich.com) was resuspended in 90% corn oil, 10% ethanol at 
50mg/ml, and heated to 55°C.  Mice were injected with 3mg/40g mouse I.P.  
 
  Immunohistochemistry 
Unless otherwise stated, wild-type mice were sacrificed at either 6- or 14-weeks of age.  
Abdominal fat tissue was dissected from mice, fixed in paraformaldehyde/PBS.  Cryo 
samples were incubated in 30% sucrose/PBS solution overnight, embedded in OCT 
(Tissue-Tek) and stored at -800C.  Paraffin samples were dehydrated through an 
ethanol series, washed three times in xylene, embedded in paraffin. Primary antibodies 
were applied over night at 4°C ,secondary antibodies were applied at room temperature 
for 1 hour (see the text for the different antibodies and dilution). To visualize nuclei, 
slides were stained with 0.5µg/ml DAPI (4',6-diamidino-2-phenylindole). Images were 
acquired using a Zeiss LSM510 Meta confocal microscope or a NIKON Eclipse 
TE2000-E.  Ki67 and BrdU cell counts were conducted by epifluorescence microscopy 
or confocal microscopy. 
 
Collagen embedding 
Collagen embedding was performed on both floating adipocytes and diluted 
stromovascular (SV) cells (1:40).  In both cases, cells were added to rat collagen type I 
hydrogel (42% collagen in DMEM), and then, following solidification, fixed in 
paraformaldehyde/PBS   Embedded adipocytes were immunostained and imaged with 
a Zeiss LSM510 Meta confocal microscope or a NIKON Eclipse TE2000-E T.  
Embedded SV cells were stained Histomark X-gal Substrate (KPL) at 37°C, stained 
with DAPI and analyzed at a Leica DM6000B microscope.  
For SV fractionation and culture, white abdominal adipose tissue was collected and 
minced into fine pieces (3 mm2). To digest, adipose pieces were incubated in adipose 
isolation buffer containing collagenase II and DNaseI at 37°C.  The filtered suspension 
was then centrifuged. The SV fraction plated in a 6-well culture dish.  The cells were 
cultured in DMEM with FBS, penicillin/streptomycin, and gentamicin for 7 days. SV 
cultured cells were fixed in  formaldehyde/glutaraldehyde. For lacZ staining all 
samples were incubated in X-gal staining buffer  at 37°C for 4 to 16 hours, post-fixed 
in formalin for 10 minutes and counterstained with DAPI.  For cell counting, stained 
cells were photographed using a Leica DFC 420 camera (Leica Microsystems Ltd, 
United Kingdom). The number of β-gal-positive cells and total nuclei were counted. 
The percentage of β-gal-positive cells was expressed as a proportion to total nuclei. 
 
FACS 
For sorting of live, unfixed adipose cells, abdominal fat was dissected from mice, 
rinsed in PBS, and cut with scissors into small pieces of approximately 3 mm in 
diameter.  The fat was then dissociated for 75 minutes in KRB solution with 
Collagenase II ,DNAse I. The homogeneous solution was centrifuged , the upper layer 
was collected and sorted on a BD FACS Calibur (Becton Dickinson). 
For sorting of fixed and stained adipose nuclei, the floating fraction is considered to 
consist primarily of buoyant adipocytes while the pelleted cells are termed 
stromal/vascular (SV) cells.  Both fractions were collected separately..  
Nuclei were extracted by incubation 1:20 in cold lysis buffer. Nuclei were fixed in 
paraformaldehyde, pelleted and finally resuspended in a solution of Tween 20 and 
paraformaldehyde in PBS for one hour before being subjected to Ki67 (PE conjugated, 
BD PharMingen) and C/EBPα immunocytochemistry, stained with DAPI and sorted 
on a BD FACS LSRII (Becton Dickinson). 
 
       Results  
No label-retaining cells are detected in adipose tissue 
To determine whether all the cells in the adipose tissue turnover at the same rate in the 
adult mouse, the tetracycline-inducible H2BGFP was used as a tool: any H2BGFP 
label-retaining cell (LRC) is thought to have incorporated the H2BGFP into chromatin 
after induction and did not replicate (histones are diluted by approximately half each 
replication cycle); if there is a reduction or total loss of GFP fluorescence this indicates 
the previously labeled cells have divided or died. No outlying population of LRCs was 
identified in the adipose tissue. The uniform loss of the H2BGFP label with time 
suggested homogeneity exists within the adipose pool. Stated otherwise, all the cells 
within the adipose tissue appear to tunover similarly.  
 
BrdU analysis suggestes 1% of murine cells within the adipose tissue are in S-phase 
per day 
In order to investigate the cellular turnover in the adipose tissue, and verify that the 
cells in the adipose tissue undergo frequent replication, we next assayed the ability of 
the cells to incorporate an artificial nucleotide analog, 5-bromo-2’-deoxyuridine  
(BrdU), via DNA synthesis.  Immunohistochemical analysis of BrdU incorporation 
found that within the Perilipin-expressing cells population, 0.6% of the cells had 
incorporated BrdU per day and that 1.8% of C/EBPα-positive cells were in S-phase per 
day. It is important to note that BrdU labeling of Perilipin-expressing adipocytes can 
also result via BrdU incorporation into replicating preadipocytes immediately prior to 
adipocyte differentiation.  
 
Approximately 5% of C/EBPα positive cells in the adipose tissue are in the cell cycle at 
any time 
We next investigated the known marker of the division Ki67 in the adipose tissue of 
C57/BL6 mice at various ages and we found that 4.8% of C/EBPα-positive cells were 
in the cell cycle at any time. FACS analysis of nuclei from dissociated fat tissue of  8 
week old wild-type mice showed that the total percentage of Ki67-positive C/EBPα-
positive nuclei in the floating fat sample was 2.36%; of this 0.45% represented 
C/EBPα-high Ki67-positive events. FACS plots of the stromal/vascular nuclei from 
dissociated fat tissue of wild-type mice, stained for Ki67 and C/EBPα showed that the 
total percentage of Ki67-positive C/EBPα-positive nuclei was 3.85%; of this 0.06% 
represented C/EBPα-high Ki67-positive events, and 3.79% represented C/EBPα-low 
Ki67-positive events. In addition, performing confocal analysis on whole-mount 
adipose tissue of 3 animals we counted a total of 4.2% of Ki67 positive nuclei, of this 
0.8% represented CD31 Ki67 positive cells, 1.8% of Ki67 positive cells were negative 
for CD31 and overlapped with Perilipin expressing cells, while for 1.5% of Ki67 
positive cells we could not determine the nature of the cellular type. 
 
Lineage analysis to investigate whether new adipocytes arise from existing adipocytes 
Because the above data suggested adipocytes may give rise to new adipocytes, we 
directly compared the replication capacity of the adipose cells by performing a lineage 
analysis of adipose tissue. We examined white adipose tissue from AP2-expressing 
cell-specific cre excizable LacZ cassette (AP2-CreER;R26R) pulse–chase animals. 
LacZ would be expressed in the cells of these animals that have expressed AP2, a gene 
expressed in adipocytes, and we did not observe loss of lacZ label with time.  
Therefore, though sufficient turnover of the adipose tissue occurs within two months to 
dilute the H2BGFP label in vivo, our preliminary experiments may suggest that one 
source of these new adipocytes may be preexisting adipocytes, as evidenced by the 
permanent, heritable lacZ labeling within fat cells. According to this hypothesis, the 
adipocyte population would be maintained at least in part by adipocyte replication. 
However we detected 1.9% of LacZ positive cells in the SV fraction that might 
represent a population of precursors which proliferate to give rise to a substantial 
proportion of adipocytes. 
 
Obese mice show increased adipose tissue replication 
To ask whether adipose tissue replication is altered in obesity, we determined the 
percentage of C/EBPα-positive cells in the cell cycle in 14-week-old wildtype and 
OB/OB mice, all of which were maintained on a C57/BL6 background. Ki67 and 
C/EBPα co-expressing nuclei were counted for both the wildtype and OB/OB groups, 
and found to be 4.6% and 7.3%, respectively. This represents a statistically significant 
increase in adipose tissue replication in OB/OB mice (p<0.05). BrdU and C/EBPα co-
labeled nuclei were counted for both groups, and BrdU incorporation was found to 
undergo a significant increase (p<0.001), from 2.9% to 9.7%, in OB/OB mice. We then 
determined the percentage of C/EBPalpha positive cells in the cell cycle in 6-week-old 
OB/OB and 14-week-old OB/OB mice. We counted the percentage of Ki67, C/EBPα 
within Perilipin expressing cells and found it to be 2.4% and 10.4%, respectively. 
 
Diet induced obesity (DIO) mice don’t show increased adipose tissue replication 
We next sought to determine whether adipose tissue replication changes in diet-
induced obese (DIO) mice. DIO mice are C57/BL6 mice fed with high fat caloric diet 
since the day of weaning. We determined the percentage of cells within the adipose 
tissue in cell cycle in 14-week-old DIO mice.  Ki67 and C/EBPα co-expressing cells 
were counted within Perilipin population  and found to be 3.6% while the total number 
of Ki67 positive cells in the adipose tissue was 4.03%. Our preliminary experiment 
didn’t show statistically significant increase in adipose tissue replication in 14 weeks 
old DIO mice compare to the wilde type animals (p>0.05). 
 
 
 
Murine adipose tissue replication is diminished  during the second half of pregnancy. 
We sought to determine whether the rate of adipose tissue replication is altered during  
mice pregnancy. The percentage of  BrdU and Perilipin co-expressing cells were 
counted for the first part of the pregnancy. BrdU incorporation was found to be 0.9% 
per day compared to 0.6% found in the non-pregnant wilde type mice control (p<0.05). 
During the second part of pregnancy we counted the percentage of  BrdU and Perilipin 
co-expressing cells and found it to be 2% any time. These was a decrease of BrdU 
incorporation over the last part of the pregnancy. We counted Ki67 positive cells 
within the Perilipin population and found to be 3.5% compare to 1.8% of the non-
pregnant wild type mice. 
 
Increased replication of adipose tissue after partial lipectomy is not statistically 
significant	  
We sought to investigate whether the rate of epididymal adipose tissue replication 
changes after lipectomy. In the lipectomized mice, we found that in the adipose tissue 
proximal to where fat was removed, 10.9% of the cells incorporated BrdU, while in the 
adipose depots where fat was not removed, 4.4% of the cells incorporated BrdU. There 
was not a statistically significant difference in replication  between the two fat 
depots(p=0.07). 
 
Evidence for replication in human adipose tisssue 
To investigate the percentage of adipose tissue replication in human, we assessed a 
known marker of cell division within the human adipose tissue in vivo from human 
tissue samples. We found 1.5% of this adipose tissue to be Ki67-positive, and, that 
0.7% of cells in adipose tissue are positive for Ki67 and C/EBPα within the Perilipin 
population at any time. 
 
 
        Conclusion and discussion 
Our experiments, allowed us to estimate the turnover rate of cells in adipose tissue 
based on the addition of new cells measured by BrdU incorporation and loss of cells 
measured by the loss of H2B-GFP in the tissue.  
The diminution of H2BGFP intensity in the adipose tissue may be explained by several 
reasons.  
∗ GFP dilution due to high replicative rate of preadipocytes and adipocytes. 
One possibility could be a high replicative rate of cell division, suggesting that all fat 
cells, mature adipocytes and preadipocytes contribute equally to fat growth and 
maintenance in wild-type mice. However, although our data, including our preliminary 
lineage tracing experiments may suggest that mature adipocytes are capable of 
replication, we cannot conclude this hypothesis since we need to provide further 
evidence of adipocytes replication. It is very important to remember that the analysis of 
adipose tissue by immunohistochemistry is quite challenging, making it very difficult 
to determine if a nuclear antigen such as Ki67 is present in the nucleus of an adipocyte. 
Thus our results cannot be considered definitive proof of mature adipocyte replication 
due to the absence of a nuclear marker for mature adipocyte. High resolution 
histological evidence demostrating fat cells with mitotic figures is critical direct 
evidence that adipocytes divide. This could be done by staining with markers of 
mitosis such as PH3, single fat cells after adipose tissue digestion. Another important 
experiment which would allow us to determine whether mature adipocytes are capable 
of replication it would be a lineage analysis with a mature marker of fat cells such as 
Leptin. 
In addition, a critical experiment would be to use our inducible CRE system to 
knockout a protein required for replication in mature adipocytes . This will then allow 
us to confirm the veracity of our assay but more importantly assess the importance of 
adipocyte replication for maintenance of adipose tissue mass under normal and 
obesogenic condition. 
Furthermore, we do not know of an example of a mature differentiated cell type that 
has two populations (one replicative and the other not). We can speculate that when 
tissues are without an adult stem cell, they are replenished by equal replication of all 
differentiated cells.  
If adipocytes divided, the adipose tissue would represent the first example of tissue that 
has both stem cells ( or progenitors ) and mature cells which divide, both maintaining 
the tissue. 
∗ Dilution of GFP due to apoptosis ,necrosis or  macrophages enfulfment. 
However, until definitive proof that mature adipocytes can undergo cell division is 
obtained, other interpretations of the diminution of fluorescence intensity have to be 
considered. One such alternative explanation for our findings could be that adipocytes 
are lost due to apoptosis, or macrophage engulfment or necrosis. This support the idea 
that adipocytes are postmitotic and that adipose tissue is maintained by stem 
cell/progenitor population. Numerous data show that adipocyte precursors are capable 
of both maintaining the progenitor pool and producing adipocytes, and indeed, we 
found evidence of replication in the SV fraction of adipose tissue in all of our 
experiments 
 
Although obesity is a metabolic disorder ultimately caused by energy imbalance, a 
greater understanding of adipose tissue growth and maintenance may one day aid in the 
treatment of obesity.  Our data support the notion of a dynamic fat cells turnover, and 
also that in the case of one of the most clinically relevant models of increased fat mass 
in mice, the rate of adipose cells replication is significantly increased.  If this is the 
case in the human population we can imagine two timepoints of therapeutic 
intervention against adipose tissue replication in cases of human obesity.  First, it is 
widely accepted that there is a substantial increase in fat cell number during 
adolescence and it is believed that an elevated number of adipocytes at the end of this 
period is a strong predictor of adult obesity.  The ability to slow the rate of the adipose 
tissue replication during this critical period of adolescent and early adult development 
may therefore prevent both juvenile and adult obesity.  Second, it may be that adult 
obesity itself is caused, or exacerbated, by elevated rates of precursor and/or adipocytes 
replication.  If this is true, targeted intervention to reduce adipocyte replication in 
adults may facilitate weight loss in obese patients. 
There are many important questions that are still open and unresolved: for example 
how do adipocytes form during development, how is proliferation regulated in adipose 
tissue, what are the dynamics of progenitors and how they are regulated during 
development and obesity…. How the turnover of adipose tissue is regulated in term of 
adipogenesis, differentiation, replication and apoptosis? Thus, the answer to these 
questions has the potential to expand our knowledge of the pathogenesis of obesity, 
and may open up possibilities for novel therapeutic approaches that may prove to be of 
great importance in the treatment of obesity and diseases associated with obesity. 
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ABSTRACT	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Because obesity is fast becoming a global health pandemic, understanding the 
molecular and cellular processes that regulate fat mass has acquired new 
importance.  Characterized by an increase in adipose tissue to the point where it 
is associated with adverse health effects, the prevalence of obesity has nearly 
tripled over the past fifty years. Though for many years adipose tissue was 
considered to be merely a storage depot for fatty acids, it is now regarded as an 
important endocrine organ involved in the regulation of energy balance, glucose 
and lipid homeostasis, blood pressure control, reproduction, inflammation and 
immune response. Obesity has an enormous economic burden and it is the 
second leading cause of preventable death. The source of increased fat mass in 
obesity is currently attributed to two mechanisms: adipocyte hypertrophy, the 
process by which pre-existing fat cells increase in size due to an accumulation 
of lipids, and adipocyte differentiation from fat precursor cells. 
Stem cells are defined by the ability to self-renew and differentiate into a 
variety of cell types. While some adult organs, including the intestine (Cheng 
and Leblond, 1974), skin (Oshima et al., 2001), blood (Spangrude et al., 1988), 
and parts of the brain (Doetsch et al., 1999; Reynolds and Weiss, 1992), are 
maintained by stem cells, others, such as the pancreas (Dor et al., 2004), are not. 
Though it was recently demonstrated that there is a substantial degree of 
cellular turnover within the human adipocyte population (Spalding et al., 2008), 
the source of new adipocytes during one’s lifetime has been entirely attributed 
to the differentiation of new adipocytes from preadipocytes and/or stem cells 
(Avram et al., 2007; Greenwood and Hirsch, 1974; Hausman et al., 2001; 
Lemonnier, 1972; Salans et al., 1971; Spalding et al., 2008; Tang et al., 2008). 
Adipocytes are thought to represent a terminal stage of differentiation and are 
widely believed to lack proliferative ability (Prins and O'Rahilly, 1997). 
Through four independent experimental approaches —dilution of an inducible 
histone 2B-green fluorescent protein (H2BGFP) through cell division, 
incorporation of BrdU, labeling with the cell cycle marker Ki67, and genetic 
lineage analysis, we aimed to investigate the adult adipose tissue maintenance 
and its behavior in the cell cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION	  	  
 
 
 
 
 
 
 
 
         1) WHAT IS ADIPOSE TISSUE? 
 
 
Fat tissue is characterized histologically as a special loose connective tissue 
containing lipid-laden adipocytes, vascular endothelial cells, fibroblasts, 
macrophages and parenchymal fibers. 
There are two principally different types of adipocytes: white and brown. These 
cells have distinct anatomy and function, different developmental attributes and 
different responses to hormonal signals. White and brown fat cells are 
organized in two tissues, the white adipose tissue (WAT) and the brown adipose 
tissue (BAT) which form a multidepot organ: the adipose organ [Cinti 2005, 
Rosen and Spiegelman 2006]. 
In mammalian organisms, the major fat depots are located either 
subcutaneously, existing in loose association with the skin, or within the body 
cavity, which include fat associated with the intestinal mesentery, fat in the 
retroperitoneum and fat surrounding the heart (fig.a). 
 
Brown adipose in rodens resides in interscapular, subscapular, axillo-toracic, 
superficial and deep cervical regions, whereas in humans it surrounds the heart 
and the great vessels in infancy but tends to disappear over time residing, in 
adults, in interscapular, supraclavicular, cervical, axillary and paravertebral 
regions. Brown fat can also be found in white adipose depots and skeletal 
muscle in small amount. [Cinti 2005,Rosen and Spiegelman 2006, Nedergaard 
2007]. 
Brown fat cells are multilocular and rich in large mitochondria containing the 
unique UCP1 protein (uncoupled protein 1) which functions to dissipate the 
proton motive force, that is normally used to drive the synthesis of cellular 
ATP, resulting in heat production. Studies in rodents also show that BAT plays 
an important role in energy balance and influences body weight. [Seale and 
Lazar 2009,Seale , Spiegelman,2009]. 
 
Fig.a The adipose organ of an adult Sv129 mouse maintained at 29 °C for 10 days. The organ has 
been dissected with the aid of a surgical microscope and each depot has been placed on the mouse 
profile mimicking its anatomical position. The organ is made up of two subcutaneous and several 
visceral depots. The most representative visceral depots are shown. Kidneys and testes were 
dissected together with the depots. Names of the single depot: A=deep cervical B=anterior 
subcutaneous (interscapular, subscapular, axillo-toracic, superficial cervical) C=visceral mediastinic 
D=visceral mesenteric E=visceral retroperitoneal F=visceral perirenal, periovaric, parametrial and 
perivescical G=posterior subcutaneous (dorso-lumbar, inguinal and gluteal). White areas made up of 
white adipose tissue and brown areas composed of brown adipose tissue are indicated by the 
scheme. Imagine taken from Cinti S 2005. 
 
 
 
Mature white adipocytes are unilocular, contain a single large lipid droplet and 
posses a spherical form that varies in size. The cytoplasm is thin and stretched 
to form a sheath that surrounds the lipid drop. Therefore, the nucleus is pushed 
against the edge of the cell, and resembled a flattened semilunar structure. Few 
mitochondria can be observed around the nucleus, with roughly arranged 
membrane cristae. The cytoplasm contains few short profiles of granular 
endoplasmic reticulum, and the Golgi zone is small. About 90% of the cell 
volume is a lipid droplet that comprises a mixture of neutral fats, triglycerides, 
fatty acids, phospholipids and cholesterol. 
Lipids stored in the fat cells are mobilized and renewed through fatty acid 
esterification and triglyceride hydrolysis which take place to release fatty acids 
into the circulation when fuel is limited, or to store excess energy [Fruhbeck 
2008]. 
 
 
Adipose tissue as an organ: Energy balance, 
glucose homeostasis and functions 
Adipose tissue had long been considered merely a storage depot for fatty acids 
and of no particular functional relevance. With the discovery of the adipose 
secreted factor Leptin, and the emergence of obesity as a serious economic 
burden and public health problem, the biology of adipose tissue has been 
acquiring scientific and medical interest. Adipose tissue is now broadly 
accepted as an important endocrine organ involved in the regulation of several 
physiological pathways, including energy balance, glucose and lipid 
homeostasis, blood pressure control, reproduction, and inflammatory and 
immune responses.[Bulcao 2006, Rosen and Spiegelman 2006]. 
 
                              Adipocytes and energy balance 
The First Law of Thermodynamics is an expression of the principle of 
conservation of energy and states that energy can be transformed (changed from 
one form to another), but cannot be created or destroyed. Between any two 
equilibrium states, the change in internal energy (E) is equal to the differences 
of the heat transfer (Q) into the system and the work (W) done by the system. 
 
E2-E1= Q-W (1) 
 
The First Law of Thermodynamic governs energy balance in animals, and can 
be expressed by this simple equation: 
 
Energy intake = energy burned + energy stored 
 
Several factors impact energy balance, including hormones and neural input, in 
addition to physiological and cultural factors [Abizaid 2006,Rosen and 
Spiegelman 2006]. It is widely believed that energy homeostasis depends upon 
the balance between caloric intake and energy expenditure, encompassing basal 
metabolism, physical activity and adaptive thermogenesis (energy spent to 
maintain body temperature and energy spent in absorbing and processing the 
diet). 
 Fig.b Weight gain is caused by a fundamental energy imbalance when energy intake from food    
chronically exceeds energy expended by physical activity and metabolic processes. Several 
studies suggested that BAT activity could impact daily energy expenditure Imagine taken from 
Seale P, Lazar M.A. Diabetes 2009. 
 
 
Lipid storage in fat cells is the result of excess energy consumption relative to 
energy expenditure (fig.b). Thus adipose tissue, through both endocrine and 
non-endocrine effects, plays a critical role in energy balance. 
To achieve a balanced energy homeostasis, fatty acids are released through 
lipolysis when energy expenditure increases, whereas less energy expenditure 
and increased food intake results in enhanced fat storage. The central and 
autonomic nervous systems (CNS, ANS) are integrated to regulate energy 
expenditure depending on physiological needs. Fat pads are richly innervated 
by sympathetic fibers that enhance lipolysis. Conversely, the parasympathetic 
nervous system positively influences lipid storage [Redinger 2009. Rosen and 
Spiegelman 2006]. 
The hypothalamic arcuate nucleus (ARC) houses two kinds of neurons: 
NPY/AgRP and POMC/CART neurons that are regulated by circulating 
hormones. During fasting, the gastric hormone ghrelin is released into the 
circulation and stimulates the ARC to release neuropeptide Y (NPY) and 
Agouti related protein (AgRP) which stimulate food intake and decrease energy 
expenditure. 
Postprandial fasting for 6 or more hours also stimulates the lateral hypothalamic 
nucleus to release the orexigenic neuropeptides orexin A and B, which increase 
caloric intake. In contrast, after a meal, insulin and adipocyte secretion of leptin, 
which increase in proportion to body adipose stores, inhibit NPY/AgRP neurons 
and stimulate adjacent POMC/CART neurons, resulting in decreased food intake 
and increased energy expenditure. Furthermore, both leptin and insulin positively 
facilitates mitochondrial beta oxidation of released fatty acid, resulting in increased 
peripheral energy expenditure [Cumming and Schwartz 2003,Redinger 2009]. 
 
 
                           Glucose homeostasis and adipose as organs 
 
In healthy mammals, serum glucose levels are relatively steady throughout the 
day, despite intermittent intake of dietary carbohydrates. Glucose homeostasis 
requires the concerted actions of various organs. For instance, increased glucose 
levels after eating leads to the release of insulin by β pancreatic cells, resulting 
in glucose disposal in adipose tissue and muscle and suppression of 
glycogenolysis and gluconeogenesis in liver. During fasting, low insulin levels 
together with elevated levels of hormones such as glucagon, adrenaline and 
corticosteroids promote hepatic glucose production. [Tirone 2001, Herman 
2006,Rosen and Spiegelman 2006]. 
Recent evidences suggest that the CNS can also coordinate many of these 
effects and affect systemic glycemia regulating gluconeogenesis. [ Herman 
2006]. 
 
Adipose tissue has recently been recognized as having important effects on 
glucose balance through several different mechanisms, endocrine as well as 
non-endocrine. Adipocytes and other cells which reside within the adipose 
tissue secrete proteins with varied effects: leptin and adiponectin (discussed 
below), visfatin, and omentin have anti-diabetic action whereas other factors 
including resistin TNF-α, IL-6, and RBP4 have pro-hyperglycaemic action 
tending to raise blood glucose. 
 
• Leptin 
The multifunctional protein leptin, secreted by adipocytes, plays an important 
role in the regulation of whole-body metabolism by inhibiting food intake, 
stimulating energy expenditure and by its anti-hyperglycaemic action. Serum 
leptin levels manifest a diurnal rhythm with the highest levels between 23:00 
and 01:00 h, after which plasma leptin declines until early afternoon. During the 
day leptin levels vary based on meal timing.[Galic 2009, Sinha 1996,Saladin 
1995] Furthermore, it has been reported that  there is a positive linear 
correlation between circulating levels of leptin and total body fat mass [Galic 
2009, Lonnqvist 1997]. The leptin receptor (Ob-R) is found in high 
concentration (30-40% of tot Ob-R) in the brain, in areas that regulate feeding 
such as the arcuate, dorsomedial, and ventromedial hypothalamoc nuclei 
[Tartaglia 1997]. It is also found in lower concentrations (5-8% of tot Ob-R) in 
several tissues including adipose tissue, pancreatic β-cells, liver, heart and 
skeletal muscle, lung, peripheral blood mononuclear cells, ovaries, testis, 
placenta, adrenal medulla, and articular chondrocytes [Galic 2009]. 
The anti-hyperglycaemic actions of leptin are mediated by direct and indirect 
effects on several target organs. Leptin determines increased insulin sensitivity 
in liver and muscle. Through the activation of AMP protein kinase and an 
indirect CNS pathway, leptin determines a reduction in intra-myocellular lipids, 
improving insulin sensitivity. [Rosen and Spiegelman 2006,Minokoshi 2002, 
Kamohara 1997]. It is also hypothesized an ‘adipo-insular axis’, with insulin 
promoting leptin release and leptin inhibiting insulin secretion. [Kieffer 2000, 
Rosen and Spiegelman 2006]. 
The role of leptin in energy balance and glucose homeostasis has been ascribed 
to genetic mutation in mammals. Ob/Ob mice ,where the leptin gene is mutated 
due to a C-T substitution leading to a non-functional gene product, and db/db 
mice, carrying a loss-of-function mutation in the Ob-R gene, are obese and 
hyperglycaemic. In keeping with this, it has been reported that the 
administration of leptin can reverse hyperglycaemia in Ob/Ob mice but not in 
db/db mice. Leptin also ameliorates glucose homeostasis in lipodystrophic mice 
and in humans with congenital leptin deficiency and lipodystrophy. [Schwartz 
1996,Shimomura 1999,Oral 2002] 
 
• Adiponectin 
The hormone adiponectin is an abundant plasma protein secreted by the adipose 
tissue. This protein contains an amino-terminal collagen-like domain and a 
carboxy-terminal globular domain that mediates multimerization. Adiponectin 
circulates in serum at extraordinary high concentrations and can exist as a 
trimer, hexamer or at highermolecular-weight dodecamers [Waki 2003,Pajvani 
2003, Barre 2006]. It has been reported that unlike other adipokines, plasma 
adiponectin concentration is negative correlated with body fat mass, with 
obesity reducing adiponectin levels, while weigh reduction increases it.[Hu 
1996, Yatagai 2003, Galic 2009]. 
Like leptin, adiponectin improves fatty acid oxidation and glucose uptake in 
skeletal muscle and adipose tissue and suppress hepatic glucose production and 
release in an AMPK-dependent manner [Tomas 2002,Wu 2003,Yamauchi 
2002, Combs 2001]. Through activation of AMPK in the hypothalamus, 
adiponectin regulates also energy expenditure stimulating appetite. 
 
 
  
 
 
 
 
 
2) WHY STUDY ADIPOSE TISSUE? 
Obesity has become a global health concern, surpassing famine and infectious 
diseases. Rapidly increasing over recent decades, obesity is characterized by an 
increase in fat mass to the extent that it causes adverse effects on health and 
longevity. Obesity is a tremendous economic burden and the second leading 
cause of preventable death in US (Flegal 2002, Ogden 2006, Kuczmarsky 2002, 
Kopelman 2000 Mokdad et al 2004). 
The etiology of obesity is multifactorial; a combination of genetic factors 
[Barsh et al 2000, Kopelman 2000] interacting with environmental factors such 
as diet, physical activity and sleep, influence the individual susceptibility to 
develop obesity. The ultimate cause of increased fat mass, however, is thought 
to be due to an energy imbalance, in which food intake exceeds energy 
expenditure. 
Chronic energy imbalance results in an increase in triglyceride stores in 
adipocytes, leading to adipocyte hypertrophy and hyperplasia. These changes in 
adipose tissue provoke endoplasmic reticulum stress and mitochondrial 
dysfunction, which in turn lead to the release of adipokines, fatty acids and 
inflammatory mediators in the blood stream. These alterations in circulating 
factors have adverse effects on skeletal muscle, heart, liver, vascular 
endothelium and pancreatic β-cells. (DeFerranti 2008, Kahn 2006, Guilherme 
2008). Consequently, obesity is associated with a number of diseases, including 
type 2 diabetes, insulin resistance, cardiovascular disease, and cancer. 
 
 
                                                                                                                                                                               Link between obesity, insulin resistance and type 2 diabetes 
It is believed that obesity plays a critical role in the development of insulin 
resistance and metabolic diseases. Insulin resistance may occur during puberty, 
pregnancy and with aging, while increased physical activity and a carbohydrate 
enriched diet are associated with enhanced insulin sensitivity. [Moran 1999, 
Buchana 1990, DeFronzo 1979, Goodyear 1998, Kahn 2006]. The mechanisms 
linking obesity to insulin resistance and type 2 diabetes are not well understood; 
though a defect in insulin release by β cells could be crucial for the 
pathogenesis of these diseases. 
In obese individuals, adipose tissue secretes increased amounts of non-esterified 
fatty acids (NEFAs), glycerol, hormones and pro inflammatory factors that have 
all been suggested to contribute to the development of insulin resistance. Under 
normal conditions, the pancreatic β cells increase insulin release sufficiently to 
overcome the reduced efficiency of insulin action, thereby maintaining normal 
glucose tolerance [Perley 1966, Polonsky 1988, Kahn 1993, 2006]. When 
insulin resistance becomes associated with type 2 diabetes, β-cells are incapable 
to compensate fully for decreased insulin sensitivity. Even when glucose levels 
are still normal, β-cells dysfunction could exist and lead to a high risk of 
developing the diseases. NEFAs are believed to be one of the major culprits as 
they have been found to induce both insulin resistance and beta cells 
dysfunction which often result in type 2 diabetes [Reaven 1988,Boden 1997]. It 
has been reported that when intracellular NEFAs increase, a competition with 
glucose for substrate oxidation occurs, leading to the serial inhibition of 
pyruvate dehydrogenase, phosphofructokinase and hexokinase II activity 
[Randle 1963, Kahn 2006]. Moreover, a decrease in fatty acids metabolism 
results in an increase of metabolites such as diacylglycerol (DAG), fatty acyl-
coenzyme A and ceramides which cause the diminish of a series of events 
downstream the insulin receptor signaling, and affect insulin sensitivity 
[Shulman 2000]. 
The distribution of body fat may play a role in insulin sensitivity. Peripheral 
distribution of fat is mostly associated with insulin sensitivity whereas 
abdominal and chest fat is linked to insulin resistance and metabolic disorders 
[Kahn 2006]. Abdominal and subcutaneous fat express different genes encoding 
secretory proteins and proteins responsible for energy production.[Kadowaki, 
2006,Maeda 1997,Kahn 2006]. Intra-abdominal adipose tissue is also more 
lipolytic and less sensitive to the anti-lipolytic effect of insulin compared to 
subcutaneous fat [Montague 2000, Kahn 2006]. 
Furthermore, nearness of the liver to the intra-abdominal fat may result in a 
greater exposure of this organ to NEFAs .This could be one of the reason of 
why the liver can be insulin resistant at a time when other distal organs are not. 
[Kahn 2006,Kim 2003]. 
In obesity, other factors released in greater quantity by the adipose tissue, are 
believed to have an important impact on the metabolism. In muscle, retinol-
binding protein-4(RBP4) induces insulin resistance through the reduction of 
PI(3)K signaling, while in liver a retinol-dependent mechanism induces the 
increase of the gluconeogenic enzyme phosphoenolpyruvatecarboxykinase, 
which contributes to enhance insulin resistance [Wellen 2005, Yang 2005, Kahn 
2006]. 
In addition, macrophages and other cells that populate the adipose tissue are 
entailed in developing insulin resistance. Proinflammatory proteins such as 
chemoattractant protein-1 (MCP-1), secreted by adipocytes, endothelial cells 
and monocyte, increase macrophages recruitment that can lead to insulin 
resistance [Kahn 2006]. 
Increased release of tumor necrosis factor-α (TNFα) and interleukin-6(IL-6) 
stimulate the c-Jun amino-terminal kinase (JNK) and the IkB-β(IKK-β)/nuclear 
factor-kβ (NF-kβ) pathway, determining upregulation of inflammatory 
mediators and thereby contribute to a feedforward process.[Kahn 2006]. 
 
Genes and environmental factors together are believed to be largely responsible 
for the development of obesity and insulin resistance. So far several genes have 
been identified to be susceptible for developing obesity, including mutations in 
the melanocortin-4 receptor genes, leptin and leptin receptor, prohormone 
convertase 1 (PC1) and pro-opiomelanocortin (POMC). Other genes are 
associated with insulin sensitivity like P12A polymorphism in PPARγ and 
several other genes are known to be associated with βcells dysfunction 
[Barroso, 2005, Kahn 2006]. 
It is thought that genes accountable for insulin resistance and obesity interact 
with environmental factors such as decreased physical activity and increased fat 
and caloric intake determining secretory demand on β cells. In case β cells are 
healthy, they increase their function and mass in response to the increased 
secretory demand, leading to compensatory hyperinsulinemia and maintenance 
of normal glucose tolerance. Whereas, susceptible β cells which have a 
genetically determined risk, are incapable of responding to the increased 
secretory demand. This, together with a nocuous environment leads to β cells 
dysfunction and decreased β cells mass, resulting in progression to impaired 
glucose intolerance followed, ultimately, by the development of type 2 diabetes 
[Kahn 2006]. 
 
Kahn and colleagues [Kahn 2006] summarize a possible model that link the role 
of impaired insulin release with obesity, insulin resistance and type 2 diabetes. 
Beta cells dysfunction results in impaired insulin secretion with decreased 
insulin levels and decreased signaling in the hypothalamus which leads to 
increased food intake and weight gain, increased hepatic glucose production, 
reduced efficiency of glucose uptake in muscle and increased lipolysis in the 
adipocyte, resulting in increased plasma NEFA levels. The increase in body 
weight and NEFAs contributes to insulin resistance. The increased glucose and 
NEFA levels together may have additional adverse effect on beta cells health 
and insulin action, causing glucolipotoxicity [Kahn 2006]. 
 
 
 
                                                                                                                               Role of obesity in metabolic syndrome and cardiovascular 
disease 
 
Central obesity, insulin resistance and type 2 diabetes together with 
hypertension and dyslipidemia are mutually related are suggested to form a 
cluster of cardiovascular risk factors which define the metabolic syndrome. 
Insulin resistance results in metabolic derangements leading to hypertension, 
dyslipidemia and an increased cardiovascular disease (CVD) risk. Adipokines 
secreted by visceral fat can have vascular consequences that increase CVD risk. 
A common item of many cardiovascular risk factors is endothelial dysfunction 
[Huang,2009]. The endothelium comprises the inner lining of blood vessels and 
not only serve as a mechanical barrier but also responds to physiological and 
pathologic stimuli producing vasoactive substances such as nitric oxide (NO), 
prostacyclin and endothelins [Huang, 2009, Gimbrone 1995, 2000]. In normal 
circumstance endothelium protects against atherogenic processes which involve 
oxidative stress, abnormalities in vascular signaling, inflammatory cells and 
thrombosis, whereas endothelial dysfunction is central to the pathogenesis of 
atherosclerotic lesion development [Ross, 1999,Steimberg 2006, Huang 2009]. 
Type 3 nitric oxide synthase (eNOS) enzyme produces NO which serves several 
functions such as the suppression on vascular smooth muscle cell proliferation, 
the 
regulation of vascular tone and regional blood flow, modulation of leukocyte-
endothelial interactions and modulation of thrombosis. When the endothelium is 
incapable of serving its normal protective and physiologic mechanism, 
endothelium dysfunction occurs. The endothelium can be damaged due to 
metabolic toxins such as free fatty acids (FFAs) and inflammatory cytokines, 
including IL-6 and TNFα. Reactive oxygen species (NOS), including 
superoxide, could prevent NO from inducing vascular smooth muscle 
relaxation. Moreover, hyperglycemia along with other metabolic abnormalities 
may alter endothelial intracellular signaling pathway such the PI3K-Akt 
pathway. 
Overall, there are multiple mechanisms that can lead to endothelium 
dysfunction, however, the endpoint is thought to be the reduction in the amount 
of bioavailable NO which normally serves to protect the vessel from the 
molecular events that lead to atherosclerosis [Huang 2005]. 
 
 
   Relationship between insulin resistance, visceral adiposity and endothelium   
dysfunction 
 
In normal condition insulin signaling culminates in glucose uptake by fat and 
skeletal muscle, vasodilatation from increased eNOS activity and suppression of 
hepatic gluconeogenesis.[Kim 2006,Semenkovich,2006, Huang 2009]. 
After insulin binds the insulin receptor, two separate and parallel pathways are 
believed to occur: PI3KAkt and Ras/Raf/MAP kinase. 
In muscle and adipose tissue, PI3K-Akt pathways results in translocation of 
GLUT4 and glucose uptake, whereas in endothelial cells causes increased NO 
production and vasodilation. 
The MAP kinase pathways results in growth and mitogenesis in vascular 
smooth muscle and determines endothelin-1 production and vasoconstriction in 
endothelial 
cells [Nystom 1999, Saltiel 2001, Huang2009]. 
The relationship between endothelial dysfunction, insulin resistance and 
visceral 
adiposity is thought to be intricate. 
Insulin resistance alters the balance between the two pathways downstreams 
insulin 
signaling and can cause endothelial dysfunction. In turn, endothelial 
dysfunction can lead to insulin resistance due to diminished blood flow and 
capillary recruitment which cause decreased substrate and insulin delivery. 
Endothelial dysfunction is also believed to lead to both insulin resistance and 
visceral adiposity by impaired mitochondrial biogenesis. A reduction of eNOS-
derived NO may lead to flaw in energy homeostasis, resulting in insufficient 
generation of energy from stored fat in white adipose tissue and insufficient 
generation of heat from brown fat. These effects might lead to increased fat 
storage. 
Visceral fat secrete adipokines and FFAs which cause insulin resistance and 
endothelium dysfunction. Resistin, IL-6 and TNFα may decrease eNOS activity 
causing less NO production. TNFα stimulates lipolysis resulting in more FFA 
release which contribute to endothelial dysfunction by a combination of 
diminished PI3K-Akt signaling, increased ROS and increased endothelin-1 
generation. 
Finally, it has also been reported that insulin resistance might contribute to 
atherogenic dyslipidemia which can lead to visceral obesity.[Huang 2009]. 
 
                                       Obesity and atherosclerosis 
In summary, it is suggested that visceral obesity together with insulin resistance 
increase cardiovascular risk by several mechanism such as glucose 
dysmetabolism, dyslipidemia and hypertension. Additionally, factors produced 
by adipocytes and macrophages such as adipokines, proinflammatory cytokines 
and procoagulant protein, may lead to increased oxidative stress and endothelial 
dysfunction, promoting atherosclerosis. [Van Gaal 2006]. Procoagulant proteins 
such as PAI-I,secreted by visceral fat, enhances thrombosis within 
atherosclerotic vessels. Visceral adipocytes also releases renin and 
angiotensinogen which contribute to hypertension by enhancing the rennin-
angiotensinogen system. 
Atherosclerosis can be accelerated due to proinflammatory and procoagulant 
adipokines secreted by white adipose fat which surrounds in excess major blood 
vessels[Trayhurn 2001,Redinger 2009]. 
The insulin resistant state of obesity, which is also characterized by increased 
levels of NEFAs, might cause lipotoxicity, impair endothelium-dependent 
vasodilation, increase oxidative stress and have cardiotoxic effect. Left 
ventricular remodeling and contractile dysfunction may results due to several 
mechanism linking central obesity and insulin resistance. 
 
  
                                Adipose tissue and cancer 
Nowdays it is suggested that the pathway of tumor formation requires several 
steps including at least six aberrations in cell physiology which lead to altered 
cell growth and the expansion of transformed cell clones. [ Hanahan 2000]. 
These alterations responsible for tumor progression depend on multifactors 
including genetic susceptibility and environmental factors.  
When malignant cells, under the influence of external signals such as 
chemokines and neurotransmitters, are capable of cell migration, cancer cell 
invasion and metastasis occur. [Entschladen 2004] 
Obesity is associated to a state of low chronic inflammation characterized by 
increased production of inflammatory cytokines which has the potential to 
affect tumor initiation and progression.[Ratke 2009]. Furthermore, recent 
studies supported the idea that leptin and adiponectin, two important adipokines 
secreted by adipose tissue and that influence energy homeostasis as well as 
metabolism and immune system, participates in the process of carcinogenesis, 
including tumor cell growth, migration and invasion and immune response 
[Lang and Ratke 2009]. 
 
 
 
 
                        Effect of adipose tissue in human pregnancy 
It has been reported that during pregnancy maternal metabolism undergos 
important changes due to the growing fetus and placenta formation. 
(Valsamakis et al.2010, Cetin I. et al. 2009).  The first trimester of gestation is 
characterized by an anabolic state in which the mother increases her adipose 
tissue deposition in order to support the development and growth of the fetus. It 
is believed that during the second part of the pregnancy fat metabolism 
switched to a catabolic condition to provide sufficient nutrients to the fetus 
which increases  its nutritional demands (Cetin et al. 2009). It is known that 
from the second to the third trimester of gestation, there is an increase of insulin 
resistance due to the increased metabolic needs of the growing fetus and 
placenta (Valsamakis G. et al 2010). The human placental lactogen, human 
placental growth hormone, prolactin, cortisol and progesterone act together in 
order to support adeguate  transfer of glucose to the fetus; these hormones 
antagonize the action of insulin leading to a state of insulin resistance over the 
course of the pregnancy. (Valsamakis et al. 2010). The adipose tissue deposition 
during pregnancy has important consequence on fetal growth. Obesity 
contributes to develop a pro-diabetogenic environment affecting the normal 
growth of the fetus (Callaway L.K et al. 2006). It has been reported that 
increased BMI before pregnancy  and increased weight during gestation have 
been associated with increased incidence of gestational diabetes mellitus, 
preeclampsia, high blood pressure and other several conditions which may 
occur during pregnancy (Catalano et al 2009, Valsamaki 2010). At cellular level 
it is known that during starvation stored fat in adipose depots undergo lipolysis 
in order to supply tisssues with fatty acids as energy substrates. Dysfanctional 
lipolysis may affect energy homeostasis and contribute to obesity and insulin 
resistance. Thus it would be important to study maternal metabolism , adipose 
tissue deposition and behaviour and their effect on the fetal growth. 
 
 
3) ORIGINS OF ADIPOSE TISSUE 
 
           Where and when does fat come from? 
 
The development of adipose tissue during embryogenesis is regulated by the 
complex interaction of cell intrinsic mechanisms, such as transcription factor 
expression, with external stimuli including adipokines, nutrients, paracrine, 
endocrine, and maternal factors [Gesta 2007, Kiess 2008]. Remarkably, early 
events in adipogenesis in the fetus have been connected to diseases manifesting 
up to several decades later. For example, maternal nutrition and change in 
glucose homeostasis during gestation may play an important role in the 
development of insulin resistance in postnatal life. [Catalano 1998, McMillen 
2006, Kiess 2008]. 
Thus, it is important to elucidate the regulation of energy homeostasis and 
adipose tissue development during embryonic, fetal, and neonatal life. 
The adipose lineage is thought to originate from mesenchymal stem cells 
(MSC), a stem cell population with rather broad developmental potential. MSCs 
develop into adipoblasts, a further restricted progenitor cell committed to give 
rise to adipocyte progenitor cells or preadipocytes, that subsequently 
differentiate into mature, lipid filled adipocytes. Although the molecular 
mechanisms directing preadipocyte differentiation into mature adipocytes have 
been characterized to some extent, the upstream events controlling MSC 
differentiation to adipoblasts and preadiopocytes are poorly understood [Ailhud 
1992, Hausman 2001]. 
Because there are no specific markers that can be used to identify adipoblasts 
and preadipocytes, very little is known regarding the origin and the 
development  
of the adipose tissue during embryogenesis [Rosen 2006,Gesta 2007]. 
 
                                          Early development 
It had long been postulated that adipose tissue is mesodermal in origin. During 
gastrulation, mesoderm formation is induced by the migration of a layer of cells 
between the primitive endoderm and ectoderm. This layer of cells, the primitive 
mesoderm, gives rise to various kind of muscle including cardiac, all connective 
tissue, blood vessels and blood, and lymph tissue. The embryonic mesoderm 
can be divided into paraxial, intermediate and lateral mesoderm. The paraxial 
mesoderm forms the bone, skeletal muscle, dermis and subcutaneous tissue as 
well as cartilage, and the ligament of the spine and base of the skull. The 
intermediate mesoderm gives rise to part of the urogenital system and the lateral 
mesoderm develops into tissues that form the pericardial, pleural and peritoneal 
cavities [Clinical anatomy by system, Richard S. Snell]. Adipose tissue is 
thought to derive from  each of these mesodermal regions.  
 
Interestingly, recent studies have shown that the mesoderm is not the only 
germ-layer source of mesenchymal cells. The neural crest (NC), composed of 
cells located dorsally in the neural tube after its closure and consequently of 
ectodermal origin, undergo an epithelial-to-mesenchymal transition and migrate 
to different regions in the developing embryo, where they differentiate into 
various cell types, including pigment cells, neuron and glia cells of  PNS and 
endocrine cells. In the head and the neck, the NC also give rise to tissue of 
mesenchymal origin such as connective tissue, vascular smooth muscle cells, 
tendons, dermis, odontoblast, cartilagines and bones [Billon 2008, Dupin 2006, 
Le Douarin 2004, Kalcheim 1999]. Recent studies have revealed that NC also is 
able to differentiate into adipocytes [Billon 2007, Gesta 2007]. In vitro 
experiments, conducted in embryonic stem (ES) cells, showed that pluripotent 
cells differentiated into NC cells could be further differentiated into adipocytes. 
Additional support came from lineage-tracing experiments in mice, where it 
was shown that adipocytes around the salivary gland and ears are derived from 
neural crest progenitors. Other connective tissues and bone in the head and neck 
have been shown to be of neural crest lineage as well [Billon 2007]. In contrast, 
other anatomically distinct units of adipose tissue, including intrascapular, 
inguinal and abdominal fat pads, have been shown to not be of neural crest 
lineage [Wrage, 2008]. These finding open new questions regarding the 
developmental ontogeny of adipose tissue, leaving us with the fascinating 
concept that adipose tissue and other connective tissues may arise from multiple 
germ layers. 
 
 
                            White-brown fat and muscle 
White and brown fat cells, having strikingly different histology and functions, 
were previously believed to be derived from the same precursor cell. However, 
a recently published in vivo fate mapping experiment in mice has provided 
evidence that brown adipocytes arise from a different and distinct population of 
progenitors expressing myf5, a marker of the myoblastic lineage [Seale, 2008]. 
Furthermore this progenitor population gives rise to both brown adipocytes and 
myocytes but fails to develop into white fat cells. (Fig.c) 
 
Several studies suggested that brown adipose tissue (BAT) activity could 
impact daily energy expenditure. [Seale and Lazar 2009]. The last several years 
have seen an explosion of information related the transcriptional control of 
brown fat cell development, differentiation and function. Recently, in vivo and 
in vitro experiments performed by Kajmura and colleagues have shown that 
PRDM16 forms a transcriptional complex with the active form of C/EBPβ, 
controlling the cell fate switch from myoblastic precursor to brown fat cells and 
suggested that forced expression of the PRDM16-C/EBPβ complex is sufficient 
to induce a fully functional brown fat program in naïve fibroblast cells. 
Furthermore they showed that transplantation of fibroblasts expressing these 
factors into mice gives rise to an ectopic fat pad with morphological and 
biochemical characteristics of brown fat, and acts as a sink for glucose uptake 
[Kajmura 2009]. It is believed that these data, indicating that the PRDM16-
C/EBPβ complex initiates brown fat formation from myoblastic precursor cells, 
may provide new opportunities to develop new therapies aimed at  treating 
metabolic disease such as obesity and type 2 diabetes. 
 
 
 
 
 
 
 
 
Fig.c. Adipocyte and myocyte differentiation from mesenchymal stem cells. Mesenchymal stem cells can 
enter several cell lineages, resulting in the formation of bone, muscle, and adipose tissue, among others. 
(a) The precursor cells destined to become white adipocytes first differentiate into adipoblasts and then 
preadipocytes through carefully timed exposure to key regulators. The determination phase results in the 
conversion of the stem cell to a preadipocyte, which still shares some morphological features with its 
precursor cell but has lost the potential to differentiate into other cell types. In the subsequent phases of 
terminal differentiation, the committed preadipocyte takes on the characteristics of the mature adipocyte 
by acquiring all the machinery needed for lipid transport, synthesis and mobilization, hormonal 
responsiveness and the secretion of adipocyte-specific proteins. Two members of the family of bone 
morphogenetic proteins (BMPs), specifically BMP2 and BMP4, as well as PPARγ and C/EBPs are pivotal 
to drive these different phases. (b) Myf5-expressing precursors give rise to skeletal muscle and brown 
adipose tissue, but not white adipose tissue. Whereas BMP2 and BMP4 promote the differentiation of the 
white adipocyte lineage, BMP7 singularly drives the brown fat cell fate in both mesenchymal progenitor 
cells and committed brown preadipocytes suppressing early adipogenic inhibitors, such as necdin, Pref-1 
and WNTs (red arrow) [30], at the same time as inducing the key molecular determinant PRDM16, which 
triggers the activation of the complete brown adipogenesis programme and blocks the induction of 
myotube-specific genes such as Myf5 and MyoD. Thus, PRDM16 operates as the key regulator in these 
myogenic progenitors inducing the commitment of the precursor to a brown preadipocyte at the same time 
as repressing skeletal muscle differentiation. Brown adipogenesis is stimulated by the transcriptional factor 
PRDM16, at least in part, via binding and coactivating PPARg with subsequent induction (green arrow) of 
key features to specify a brown fat fate (i.e. increased mitochondrial biogenesis and expression of p38 
MAPK, UCP1, Cidea, and Elovl3, among others, which lead to a mature brown adipocyte phenotype). 
Simultaneously, PRDM16 suppresses myogenesis, thereby decreasing the expression of myogenic genes 
such as MyoD, myogenin, myocyte enhancer factor 2 (MEF2) and myogenic related factor 4 (MRF4). 
Some aspects of the differentiation pathways still remain uncertain. Because the differentiation programme 
is complex and orchestrated by multiple factors intervening at diverse steps, the figure only presents a 
tentative placement of some of them. Chronic cold exposure or prolonged catecholaminergic stimulation 
are followed by the emergence of brown adipocytes in white adipose tissue. Interestingly, these brown fat 
cells seem to have an independent origin to that of the myogenic-derived lineage. The question marks 
represent some plausible steps that still need to be elucidated, such as the possibility of emergence of 
brown adipocytes from a common adipoblast-derived precursor, and the potential transdifferentiation 
between the developmentally distinct adipocytes.  
Picture and legend are taken from Fruhbeck et al. Cell press 2009 
 
 
 
                   Adipose tissue development during fetal life 
Very little is known regarding adipose tissue during embryonic development in 
mice. There is as of yet no evidence of white adipose tissue (WAT) being 
present during fetal life while interscapular BAT can be detected. 
The only specific marker for adipose tissue during both fetal and postnatal life 
is adipocyte protein 2 (aP2). aP2 also called Fatty Acid Binding Protein 4 
(FABP4), is a cytosolic fatty acid chaperone protein found predominantly in 
mature adipocytes, where it facilitates the utilization of lipids in metabolic 
pathways (Maeda et al. 2005; Makowski et al.).  However, its role during fetal 
development is not clear. 
Sumithra and collagues investigated the expression of Cre recombinase under 
the control of the promoter for the aP2 gene in a lineage tracing experiment [He 
et al. 2003], and they demonstrated that the aP2-Cre transgene is expressed and 
consistently localized within the embryo from mid-gestation stage 9.5 dpc (day 
post coition), and by 15 dpc transgene expression was detected primarily in 
BAT, trigeminal ganglia, dorsal root ganglia, cartilage primordial and vertebrae 
[ Urs  2006].(fig.d)  
 
 
Fig.d Timeline of mouse embryonic development: gastrulation , the process which give rise to 
the 3 germ layers, occur around stage 6.5 dpc; specification of organs happens around 8.5-
10.5dpc. aP2-Cre transgene has been shown to localized withing the embryo from midgestation 
stage 9.5dpc 
 
 
In humans, adipose tissue can be detected during embryonic development and at 
birth [Kiess 2008]. Fat cells are first noticeable between the 14th and 16th weeks 
of gestation, suggesting the second trimester of gestation as the critical period 
of adipogenesis  [Aihaud 1998, Poissonet 1984, Niemela 2007, Kiess 2008]. 
Around the third semester, relatively small adipocytes are already detectable in 
the principal sites of fat deposition. During early development no differences in 
WAT localization between male and female fetuses has been described, 
suggesting that such differences develop gradually later in life, presumably due 
to differential effects of sex hormones [Kiess 2006, Aihaud 1998, Enzi 1980]. 
During the late gestation there is an increase in BAT specific expression of 
UCP1, which is activated at birth and determines heat production. Then, during 
postnatal life BAT, and UCP1 expression,  gradually disappears [Niemela 2007, 
Enzi 1981, Kiess 2008]. 
 
                                        Adipogenesis 
 
The physical events determing the transition from preadipocytes to mature 
adipocytes have been studied in vitro in mouse 3T3-L1 and 3T3-F442A cell 
lines and immortalized brown preadipocytes cell lines [ Rosen and Spiegelman 
2000]. The process of terminal adipocyte differentiation can be divided into 
several distinct stages. After a brief proliferative burst, adipocytes undergo 
growth arrest in G0-G1 of the cell cycle. Upon exposure to mitogens, 
differentiating agents and hormonal induction, growth-arrested preadipocytes 
re-enter the cell cycle and undergo several rounds of cell division, known as 
mitotic clonal expansion. Subsequently, terminal differentiation is associated 
with the expression of the nuclear receptor PPARγ, C/EBPα, and lipid droplet 
formation [Gesta 2007, Hausman 2001, Lefterova 2009]. 
 
It is noteworthy that there are significant differences between in vivo adipose 
tissue and cell lines cultured in vitro. The expression levels of the adipogenic 
transcriptional regulator KLF4, leptin, and TNFα are higher in vivo than in 
vitro. [Gesta 2007, Rosen and Spiegelman 2000, Soukas 2001] Furthermore, 
adipocyte cell lines are often aneuploid, which may influence the adipogenic 
transcriptional program during differentiation [Rosen and Spiegelman 2000]. 
Additionally, primary cultures of stroma vascular cells can differentiate without 
undergoing the clonal expansion stage, [Entenmann 1996, Rosen and 
Spiegelman 2000], which is contraty to the current model of adipocyte 
differentiations. Furthermore, the most studied preadipocytes cell line (3T3-l1) 
is derived from a mouse embryonic fibroblast cell line, not adipose tissue ( 
Stembook : Cook, Cowan 2009). Thus, it is likely that in vivo experiments may 
provide additional insights into the transcriptional cascade of events leading to 
mature adipocyte differentiation. 
 
 
                              The molecular cascades controlling adipogenesis 
The transcriptional cascade controlling adipocyte differentiation has been 
investigated intensely. Peroxisome proliferator-activated receptor gamma 
(PPARγ) and CCAAT /enhancing binding protein (C/EBPs) are considered the 
master regulators of adipogenesis. PPARγ and C/EBPα constitute a self-
regulatory feedback loop and activate the expression of genes controlling 
terminal differentiation of adipocytes.  
 
PPARγ is a member of the nuclear hormone receptor superfamily and is 
required for the development of adipocytes. There are 3 isoforms, with PPARγ2  
being specific to adipocytes. Deletion of PPARγ in mice results in placental 
dysfunction and embryonic lethality [White and Stephens 2009, Barak 1999, 
Rosen 1999]. Furthermore, PPARγ has been described to be necessary and 
sufficient for adipogenesis. [Tontonoz and Spiegelman 2008]. PPARγ binds 
DNA as a heterodimer with retinoid X receptor (RXR), thereby promoting the 
expression of its target genes. The molecular basis for how the PPARγ-RXR 
heterodimer binds to DNA has recently been elucidated [See Chandra 2009 for 
details]. 
C/EBPα,β, and δ belong to a family of highly conserved basic-leucine zipper 
proteins and they were the first family of transcription factors shown to play a 
critical role in the differentiation of adipocytes in vitro. Additionally, in vivo 
studies demonstrated that transgenic mice lacking these factors have defective 
fat cell differentiation [White and Stephen 2009, Tanaka 1997, Wang 1995].  
C/EBPα is expressed late in adipogenesis and is most abundant in mature 
adipocytes, where it is crucial for insulin-dependent glucose uptake [Wu 1999, 
White and Stephens 2009]. However, while PPARγ has shown to be necessary 
for adipogeneis, elegant in vivo studies have shown that C/EBPα is dispensable 
in adipogenesis [Rosen 2002]. 
Although PPARγ and  C/EBPα are considered the two primary transcription 
factors that mediate adipogenesis, and PPARγ is critical for fat cell 
differentiation, these transcription factors are under control of several other key 
transcriptional modulators. (White and Stephens 2009).fig., For example, 
members of KLF family, STAT5 and SREP-1c have been shown to play a role 
in promoting adipogenesis. Additional factors affect this chain of events. For 
example, KLF2, E2F, CHOP, members of the Wnt ligand family, delta-
interacting protein A, ETO/MTG8 and members of the GATA transcriptional 
factor family have all been shown to negatively regulate adipogenesis 
[Lefterova 2009, White and Stephans 2009, Farmer 2006]. 
 
 
 
 
 Fig.e Trancription factor activation and expression during adipogenesis (White and Stephens,2009). 
 
 
 
 
4) GROWTH AND MAINTENANCE OF ADIPOSE TISSUE  
 
It is widely believed that the total number of fat cells present in most 
individuals is set during adolescence and that changes in fat mass generally 
reflect increased lipid storage in a fixed number of adipocytes [Hirsch, J. & 
Batchelor, B 1976, Bjorntorp, P 1974, Spalding K.L, 2008]. Though it was 
recently demonstrated that there is a substantial degree of cellular turnover 
within the human adipocyte population [Spalding 2008], the source of new 
adipocytes during one’s lifetime is attributed to the differentiation of new 
adipocytes from preadipocytes and/or stem cells [Hirsch, J. & Batchelor, B 
1976, Spalding K.L, 2008, Tang, W 2008].  
Preadipocytes are generally considered to be replicative [Miller, W. H., Jr., 
Faust, I. M. & Hirsch, J. 1984, Staszkiewicz, J. et al. 2008] until the onset of a 
transcription factor cascade driving adipogenesis [Tontonoz, P. & Spiegelman, 
B. M.  2008, Rosen, E. D., Walkey, C. J., Puigserver, P. & Spiegelman, B. M. 
2000] causes growth arrest [Altiok, S., Xu, M. & Spiegelman, B. M. 1997]. 
Additionally, primary adipocytes seemingly lack proliferative activity in vitro 
[Hiragun, A. 1985] and cell culture lines capable of adipocyte differentiation 
undergo cell cycle arrest during differentiation. [Gregoire, F. M., Smas, C. M. 
& Sul, H. S. 1998]  Adipocytes are thought to represent a terminal stage of 
differentiation and are believed to lack proliferative ability [Prins, J. B. & 
O'Rahilly, S 1997]. Thus, data from in vitro experiments all suggest that one or 
several of stem and/or progenitor cell populations give rise to new adipocytes 
during postnatal life.  
However, it is important to remember that in vitro models have their limitations 
although they can recapitulate some of the characteristic of adipocyte 
differentiation in vivo. For example, 3T3-L1 cells, when injected into mice, 
differentiated and formed fat pads that were indistinguishable from normal 
adipose tissue [Green and Kehinde, 1979], and a population of progenitor cells 
capable of differentiating into adipocytes can also be purified based on cell 
surface marker expression and transplanted into lipodystrophic mice to 
reconstitute fat depots [Rodeheffer, M. S., Birsoy, K. & Friedman, J. M. 2008].  
Despite this and other examples of successful transfer of cell culture models to 
the in vivo system [Farmer, 2006, Ross et al. 2000, Lazar, 2005], in vitro culture 
models can still not be considered to perfectly mimic the in vivo situation. They 
can rather be viewed as simplified systems of adipogenesis that offer 
opportunities to more conveniently modulate expression and activity of key 
molecules controlling the genetic program of adipogenesis.[ MacDougald and 
Mandrup, 2002]. However, it is important to verify findings from in vitro 
experiments in vivo as there are numerous examples of differences when 
comparing development of fat in tissue culture and in the living organism. For 
instance, cell culture medium and conditions are far from resembling in vivo 
conditions, and some genes show differential effect and expression in vitro and 
in vivo [ Tanaka et al, 1997]. Furthermore, the growth arrest due to contact 
inhibition and the subsequent clonal expansion might be an event that occur in 
cell culture system and not in vivo.  
An additional limitation of in vitro experiments is that they require that stem 
and progenitor cells are removed from their anatomical location in the body, 
thereby disrupting the microenvironment where they normally reside. It has 
been shown that this microenvironment, or niche, provides factors and signals 
that contribute to maintain the stem-like capacity of progenitor cells. Well-
documented stem cell niches have been described for the hematopoietic, 
epithelial, neural and intestinal systems [Xie and Li, 2007].  In fat tissue, 
progenitor cells with the capacity to differentiate into adipocytes were 
suggested to reside in the adipose stromal-vascular (SV) compartment two 
decades ago [Ailhaud et al 1992]; however, the adipose SV progenitors had 
been studied after enzymatic digestion and density separation from adipocytes, 
resulting in disruption of any existing structure and loss of anatomical context 
of adipose progenitors [Hausman et al, 1980]. Furthermore, the lack of markers 
for adipocyte progenitor cells made it difficult to definitively identify 
progenitor structures. 
Adipose tissue is highly vascualarized and every adipocyte is juxtaposed with 
multiple capillaries [Crandall et al., 1997]. Hausman and Richardson proposed 
that adipose development temporally and spatially correlates with vascular 
development (Hausman and Richardson, 1994).  However, experimental 
evidence for direct involvement of vascular componets in adipogenesis was not 
presented. Several interacting cell types, including endothelial cells and mural 
cells, form the blood vessels. Mural cells, mainly vascular smooth muscle cells 
and pericytes, are important regulators of blood flow, vascular permeability and 
blood vessel development. It has been shown that cultured mural cells display 
remarkable plasticity and can undergo adipogenesis, chondrogenesis, 
myogenesis and osteogenesis [Farrington-Rock et al., 2004, Dellavalle et al., 
2007, Doherty et al., 1998], similar to mesenchymal stem cells [Pittenger et 
al.,1999]. Thus, mural cells had been suggested to be a potential progenitor cell 
reservoir in vivo. 
 
As evident from the above, although several hypotheses had been put forth, 
surprisingly little has been known about adipose tissue in vivo because of the 
lack of genetic tools. 
However, in a recent elegant study Tang and colleagues were able to genetically 
mark adipose progenitors with GFP, allowing direct visualization of progenitors 
cells with the capacity to differentiate into adipocytes. Furthermore, this pool of 
progenitors was suggested to reside adjacent to the adipose vascular tissue 
[Tang W. et all, 2008].  
As discussed above, peroxisome proliferator-activated receptor gamma 
(PPARγ), a central regulator of fat formation, is necessary and sufficient for 
adipogenesis [Lazar M. 2005, Farmer S. 2006]. By generating PPARγ–tet 
transactivator (tTA) [Kistner A, 1996] knock-in mice placing tTA under the 
control of the PPARγ locus, and leading to Cre expression, Tang and colleagues 
were able to capture the expansion of the adipose lineage that, according to 
several previously published reports [G. Ailhaud, P. Grimaldi, R. Negrel,1992, 
J. R. Cook, L. P. Kozak,1982], occurs during the first postnatal month. After 
they Dox-treated PPARγ-R26R mice, starting at different days during this 
crucial window, they found that adipose lineage cells, already instructed to 
express PPARγ prenatally, proliferate and are the major source of the spurt of 
adipocyte development observed in the first month of life. They also found that 
these progenitors reside in the mural cell compartment of the adipose 
vasculature, but not in the vasculature of other tissues. Thus, the experimental 
evidence that strongly supports the notion that the adipose vasculature appears 
to function as a progenitor niche and may provide signals for adipocyte 
development. [Tang W et all, 2008]. However, it is currently not known if there 
are other populations of progenitors with adipogenic potential postnatally, nor 
has it been definitively determined if adipocytes can replicate in vivo. 
 
 
How adipose tissue is regulated is a central question in the study of obesity. 
Obesity is commonly considered to be a disorder of energy imbalance in the 
organism.  At the cellular level, however, the development of obesity has been 
attributed to both an increase in fat cell size, fat cell differentiation and 
increased adipocyte number [Bjorntorp, P. et al. 1995, Sjostrom, L. & 
Bjorntorp, P. 1974, Faust et al, 1978, Wise 1975]. The notion that adipocytes 
can undergo replication has existed for decades  [Zhang, H. H., Kumar, S., 
Barnett, A. H. & Eggo, M. C. 2000; Klyde, B. J. & Hirsch,1979, Klyde, B. J. & 
Hirsch, 1979] but has not been widely accepted. 
 
There are many important questions that are still open and unresolved: for 
example how do adipocytes form during development, how is proliferation 
regulated in adipose tissue, what are the dynamics of progenitors and how they 
are regulated during development and obesity….  
Thus, an understanding of how adipocyte number is regulated postnatally has 
the potential to expand our knowledge of the pathogenesis of obesity, and may 
open up possibilities for novel therapeutic approaches that may prove to be of 
great importance in the treatment of obesity and diseases associated with 
obesity. 
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We sought to investigate the growth and maintenance of the adipose tissue and 
its behaviour in the cell cycle through 4 independent experimental  approaches: 
1. dilution of an inducible histone 2B-green fluorescent protein (H2BGFP)   
through cell division. 
2. DNA-replication dependent incorporation of the nucleotide analog 
BrdU. 
3. labeling with the cell cycle marker Ki67  
4. lineage analysis of adipose tissue by using AP2-CreER transgenic mice 
to investigate whether newly formed fat cells are derived from pre-
existing adipocytes or stem/precursor cell 
 
